glp-1 als Science's 2023 Breakthrough: GLP-1R Agonists GLP-1 Receptor Agonists as Treatments

Recently, Takai et al

Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellstrm PM (2005) Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY

During the title/abstract screening phase, 1265 studies were excluded due to failure to meet the study objectives

I also started using my blood glucose to avoid the hypos I started getting when Ozempic was added to my three other meds

Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial

Elkind-Hirsch et al